Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5. This appears to be a minor maintenance update to the page’s versioning, with no visible changes to study data or user-facing content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new revision label, v3.5.4, has been added. The previous label v3.5.3 has been removed.SummaryDifference0.0%

- Check46 days agoChange DetectedThe ClinicalTrials.gov page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the displayed study details.SummaryDifference0.0%

- Check53 days agoChange DetectedOno Pharmaceutical Co., Ltd. and Revision: v3.5.2 were added, while Ono Pharmaceutical Co. Ltd and Revision: v3.5.0 were removed.SummaryDifference0.0%

- Check67 days agoChange DetectedUpdated the location entry from Padua, Italy, 35128 to Padova, Italy, 35128 in the study locations.SummaryDifference0.0%

- Check82 days agoChange DetectedVersion updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.